Chittorgarh.com Logo
Loading...

Par Drugs IPO Subscription Details (Live Status)

Par Drugs IPO Details

Issue Open May 3, 2019
Issue Close May 8, 2019
IPO Price ₹51
Face Value ₹10
IPO Size ₹8.53 Cr
Listing At NSE SME
IPO Lot Size 2000

Par Drugs IPO Subscription Status Live

Par Drugs IPO subscribed 5.74 times. The public issue subscribed 7.97 times in the retail category, [.] times in QIB, and 3.48 times in the NII category by May 8, 2019.

Investor CategorySubscription (times)
Qualified Institutions[.]
Non-Institutional Buyers3.48
Retail Investors7.97
Employees1.00
Others[.]
Total5.74

Par Drugs IPO Subscription Details (times)

DateNIIRetailEMPTotal

Day 1
May 3, 2019

0.23

0.15

1.00

0.21

Day 2
May 6, 2019

0.61

0.79

1.00

0.72

Day 3
May 7, 2019

0.89

1.85

1.00

1.39

Day 4
May 8, 2019

3.48

7.97

1.00

5.74


Par Drugs IPO Shares Offered

Par Drugs IPO is a public issue of 1,558,000 equity shares. The issue offers 780,000 shares to retail investors, 0 shares to qualified institutional buyers, and 778,000 shares to non-institutional investors.

CategoryShares Offered%
NII778,00049.94%
Retail780,00050.06%
Employee30,0001.93%
Total1,558,000100%

IPO Investor Categories

  • Qualified Institutional Buyers (QIB)

    Financial Institutions, Banks, FIIs, and Mutual Funds registered with SEBI are called QIBs. In most cases, QIBs represent small investors who invest through mutual funds, ULIP schemes of insurance companies, and pension schemes.

  • Non-Institutional Investors(NII)

    Individual investors, NRIs, companies, trusts, etc who bid for more than Rs 2 lakhs are known as Non-institutional bidders or NII. They need not register with SEBI like QIIs.

  • Retail Individual Investors(RII)

    The retail individual investor or NRIs who apply up to Rs 2,00,000 in an IPO are considered as RII reserved category.

  • Employee (EMP)

    A category of eligible employees who have a reserved quota in the IPO.

  • Others

    A category of eligible shareholders or other investors who have a reserved quota in the IPO.

Par Drugs IPO Subscription FAQs

The Par Drugs IPO is subscribed 5.74 by May 8, 2019.

Par Drugs IPO Subscription

Investor CategorySubscription (times)
Qualified Institutional[.]
Non Institutional3.48
Retail Individual7.97
Employee Reservations1.00
Others[.]
Total Subscription5.74

Retail category of Par Drugs IPO subscribed 7.97 times as of date May 8, 2019. The public issue closes on May 8, 2019 for bidding.

An investor can apply in Par Drugs IPO online via bank (using ASBA) or the broker (using UPI). The Par Drugs IPO shares are offered online only.

The Par Drugs IPO is subscribed 5.74 by May 8, 2019.

The Par Drugs IPO allotment status is expected on or around May 13, 2019. Visit Par Drugs IPO allotment status to check.

The Par Drugs IPO listing date is Thursday, May 16, 2019. The equity share of Par Drugs and Chemicals Limited will list on NSE SME.

Visit Par Drugs IPO subscription status page for real-time bidding information about Par Drugs IPO.

Par Drugs IPO Timetable

IPO Opens OnMay 3, 2019
IPO Closes OnMay 8, 2019
Finalisation of Basis of AllotmentMay 13, 2019
Initiation of RefundsMay 14, 2019
Credit of Shares to Demat AccountMay 15, 2019
IPO Listing DateMay 16, 2019